ReviewNature reviews. Urology2011
A decade in prostate cancer: from NMR to metabolomics.
Review in Nature reviews. Urology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Exploring metabolic signatures in urine using NMR for improved prognosis of gliomas.Metabolomics : Official journal of the Metabolomic Society · 2026Article
- Urinary Metabolomic Analysis of Prostate Cancer by UPLC-FTMS and UPLC-Ion Trap MSDiagnostics (Basel, Switzerland) · 2023Article
- Association of altered metabolic profiles and long non-coding RNAs expression with disease severity in breast cancer patients: analysis byMetabolomics : Official journal of the Metabolomic Society · 2023Article
- Guide to Metabolomics Analysis: A Bioinformatics Workflow.Metabolites · 2022Review
- NMR based CSF metabolomics in tuberculous meningitis: correlation with clinical and MRI findings.Metabolic brain disease · 2022Article
- Novel Metabolic Signatures of Prostate Cancer Revealed byDiagnostics (Basel, Switzerland) · 2021Article
- Non-invasive biomarkers for monitoring the immunotherapeutic response to cancer.Journal of translational medicine · 2020Review
- Treatment With Hydrolyzed Diet Supplemented With Prebiotics and Glycosaminoglycans Alters Lipid Metabolism in Canine Inflammatory Bowel Disease.Frontiers in veterinary science · 2020Article
- Molecular Characterization of Prostate Cancer with Associated Gleason Score Using Mass Spectrometry Imaging.Molecular cancer research : MCR · 2019Article
- NMR-based metabolomics studies of human prostate cancer tissue.Metabolomics : Official journal of the Metabolomic Society · 2018Review
- Article
- Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211.Medical physics · 2017Article
- Nuclear Magnetic Resonance technique in tumor metabolism.Genes & diseases · 2017Review
- Metabolomics connects aberrant bioenergetic, transmethylation, and gut microbiota in sarcoidosis.Metabolomics : Official journal of the Metabolomic Society · 2016Article
- Metabolomic profiling of hormone-dependent cancers: a bird's eye view.Trends in endocrinology and metabolism: TEM · 2015Review
- Translational metabolomics in cancer research.Biomarkers in medicine · 2015Review
- Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6.British journal of cancer · 2014Article
- Chemistry and biochemistry of 13C hyperpolarized magnetic resonance using dynamic nuclear polarization.Chemical Society reviews · 2014Review
- Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.World journal of gastroenterology · 2014Article
- Sarcosine as a potential prostate cancer biomarker--a review.International journal of molecular sciences · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Over the past 30 years, continuous progress in the application of nuclear magnetic resonance (NMR) spectroscopy and magnetic resonance spectroscopic imaging (MRSI) to the detection, diagnosis and characterization of human prostate cancer has turned what began as scientific curiosity into a useful clinical option. In vivo MRSI technology has been integrated into the daily care of prostate cancer patients, and innovations in ex vivo methods have helped to establish NMR-based prostate cancer metabolomics. Metabolomic and multimodality imaging could be the future of the prostate cancer clinic--particularly given the rationale that more accurate interrogation of a disease as complex as human prostate cancer is most likely to be achieved through paradigms involving multiple, instead of single and isolated, parameters. The research and clinical results achieved through in vivo MRSI and ex vivo NMR investigations during the first 11 years of the 21st century illustrate areas where these technologies can be best translated into clinical practice.
Indexed as
Identifiers
21587223What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.